Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)
Google Reviews Lifestyle Med Spa - Agoura Hills Health Services, Weight Loss, IV Therapy & Hydrafacial 48 Google reviews Tonya RoseTrustindex verifies that the original source of the review is Google.Im 35 lbs down and look and feel better than I have in 10+ years
Increased constipation risk Constipation affects around 24% of people taking Wegovy, making it one of the most common and persistent side effects in clinical trials
Even as the intensity may diminish slightly, the ongoing effects of reduced hunger and cravings remain, helping patients stick to a calorie-controlled diet
According to FDA labeling, the injection can be administered in the morning, afternoon, or evening with consistent efficacy